Admetsys

Admetsys has developed the first fully-automated glucose control system (artificial pancreas) specifically for the needs of hospital & surgical care. 〽️

[Admetsys @admetsys]

Join Admetsys at 14:30pm GMT on 2nd December 2020 online at GIANT 2020 @gianthealthevnt to learn more about Admetsys' PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System for Hospital and Surgical Care. https://t.co/95jgv0dSml

[Mass Technology Leadership Council @MassTLC]

#TechTop50Honoree Congrats to .@admetsys for their PrecisionOne system that functions as a metabolic autopilot, providing automated gluclose regulation and real-time blood chemistry analysis for diabetes patients👏 #Innovation

[Admetsys @admetsys]

Admetsys is honored to join @1up_health @athenahealth @AGmobilerobots @BIOMODEX @CardioLogs @Indigoag @NexthinkNews @Voatz and @Wevoconversion as a @MassTLC outstanding tech company for innovation in 2020 at the #TechTop50 digital experience. https://t.co/b2rwCJyVU4

[Admetsys @admetsys]

Admetsys is honored to join @1up_health @athenahealth .@AGmobilerobots @BIOMODEX @CardioLogs @Indigoag @NexthinkNews @Voatz and @Wevoconversion as an @MassTLC outstanding tech company for innovation in 2020 at the #TechTop50 digital experience.

[Mass Technology Leadership Council @MassTLC]

Congratulations to you all on your amazing work!

[Mass Technology Leadership Council @MassTLC]

Congrats to @admetsys for being recognized as a #TechTop50 for their innovation in 2020! Well done! 🎉

[Admetsys @admetsys]

Admetsys is honored to be nominated to the @MassTLC Tech Top 50 program for the recent CE Mark approval of the novel PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System. #ThankYou https://t.co/Fa7gQlKC47

[Admetsys @admetsys]

Admetsys Secures CE Mark Approval for PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System 👏👏👏👏 https://t.co/95jgv0dSml

[Admetsys @admetsys]

Poorly-controlled glucoses in hospitalized #COVID19 patients increases death rates significantly. "These findings provide clinical evidence correlating improved glycemic control with better outcomes in patients with COVID-19 and pre-existing T2D." https://t.co/ARCA66hw6O

[Admetsys @admetsys]

Admetsys is proud to announce that we have received a CE mark in Europe. Thank you to all of our advocates, advisors and investors for helping us change the landscape of hospital care. @T1DExchange @dreamit @BaptistHealthAR @ArkBlueCross @ZellLurie

[Synthetic.com @syntheticdotcom]

In Conversation: Admetsys CEO Jeff Valk https://t.co/52MJa51E6O @admetsys

[MedStartr @MedStartr]

All the companies did amazing last night. Thank you to everyone who help made this possible.

The Finale Results on the war on COVID Competition

1 st place Lincoln advantage technologies

2nd place @admetsys

And a tie for crowd favorite
@PhenoMxInc
and
@elemenohealth

[MedStartr @MedStartr]

Come watch the companies that are changing the healthcare landscape and addressing #COVID19 head on! #WarOnCovid
@helpsyhealth @f2fhealth @elemenohealth @EmanateWireless @PhenoMxInc @healthmodeHQ @admetsys, and rivertown bioscience. Plus 2 wildcards!
https://t.co/7McjvpLKm6

[Admetsys @admetsys]

@elonmusk When is the CyberJeep coming? We need something to look forward to as we work through this rough patch for everyone.

[Reuters Events Pharma @RE_Pharma]

The Health Start-Up Challenge returns! Watch Joe Buffone @annexushealth, Kevin Bambury @ONCOassist, @jordanlmills @mirrorme3d, Jeff Valk @admetsys & @patanq @portalcambridge deliver their pitches. YOU decide who wins, vote here: https://t.co/0vPid8NETF #efpvirtual

[Admetsys @admetsys]

Watch @Admetsys present on creating value for patients and healthcare at #efpPhilly @eyeforpharma Philadelphia Virtual, the largest commercial pharma conference, on April 14th at 5 PM ET. Register at https://t.co/JckSwmFIGX #ArtificialPancreas #T1D

[Admetsys @admetsys]

Thank you to @MedStartr @Health2eu #Health20NYC for allowing us to join the #WarOnCOVID Challenge during these unique times. We look forward to working with you and other innovators as we jointly work towards mitigating #COVID19 and supporting medical staff and patients.

[MedStartr @MedStartr]

The winners of #WarOnCovid Heat 3 Contest! #medmo2020

1st place @f2fhealth
2nd place @admetsys
And a tie for third between
@tamarinhealth and Montfort Brain Monitor

[Health Finance Institute @HealthFinInst]

We analyzed @CDCgov prevalence of #ChronicDisease and #COVID19 data: those w/ #diabetes infected w/ #COVID19 are ~7 times as likely to need the ICU vs. those w/o diabetes.
#NCDs prevention saves health systems & lives:
@WHO @DrEricDing @andreafeigl1 @sandrogalea @ncdalliance

[Admetsys @admetsys]

See @Admetsys and other great innovators present online tomorrow as part of the @MedStartr @Health2eu #Health20NYC #WarOnCOVID Challenge as we work towards mitigating #COVID19 through information-driven scalable diagnostics and automated care. Join via https://t.co/YQAJTKBZk8

[Mohammed Bin Rashid Innovation Fund @MBRIFund]

The MBRIF has two distinct offerings for startups: 1. Accelerator 2. Government backed guarantees. Admetsys, a Boston based medical startup, was a member of our accelerator’s first cohort. This facilitated their growth in the UAE & other countries outside of their home turf.
👇

[Mohammed Bin Rashid Innovation Fund @MBRIFund]

Their accelerator journey enabled them to kick-off qualification discussions for the Guarantee Scheme, which provides financial solutions for innovative companies. Get in touch and learn more here: https://t.co/97EjBQVVdd
#MBRIF